Skin and Soft Tissue Infections
📧 Sign up to get email alerts when something new happens for Skin and Soft Tissue Infections.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-12-12Clinical Trial Update: Study of Accuracy of New Diagnostic Technology to Determine Guide Rapid Antibiotic Treatment for Serious Infections
A completed clinical trial assessed the accuracy of a new diagnostic technology intended to guide rapid antibiotic treatment for serious inf…
-
EMA approval · 2025-09-26EMA Authorised: Tigecycline Accord (tigecycline) — Accord Healthcare S.L.U.
The European Medicines Agency authorised Tigecycline Accord (tigecycline) for use by Accord Healthcare S.L.U. for soft tissue infections, in…
-
EMA approval · 2025-09-09EMA Authorised: Zinforo (ceftaroline fosamil) — Pfizer Ireland Pharmaceuticals
The EMA authorised Zinforo (ceftaroline fosamil) for community-acquired infections, including pneumonia and skin and soft tissue infections,…
-
FDA approval · 2025-08-21FDA Approved: MEROPENEM — Supplemental Application (BluePoint Laboratories)
FDA approved a supplemental application for Meropenem submitted by BluePoint Laboratories (ANDA205883), confirming approval of a supplementa…
-
CLINICAL_TRIALS trial_result · 2025-07-17Clinical Trial Update: Chlorhexidine Impregnated Cloths to Prevent Skin and Soft Tissue Infections in Marine Officer Candidates [NA]
Clinical trial evaluated chlorhexidine-impregnated cloths to prevent skin and soft tissue infections in Marine Officer Candidates; the study…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2025-05-29FDA Approved: LINEZOLID — Supplemental Application (Hospira, Inc.)
FDA approved a supplemental application for LINEZOLID submitted by Hospira, Inc.
-
EMA approval · 2025-03-20EMA Authorised: Sivextro (tedizolid) — Merck Sharp & Dohme B.V.
The European Medicines Agency authorised Sivextro (tedizolid) by Merck Sharp & Dohme B.V. for the treatment of soft tissue infections and ba…
-
FDA approval · 2024-11-19FDA Approved: ZOSYN IN GALAXY CONTAINERS — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)
FDA approved a supplemental application to allow Zosyn in Galaxy containers (piperacillin/tazobactam), a packaging/formulation change from W…
-
FDA approval · 2024-10-10FDA Approved: LINEZOLID — Original Application (Macleods Pharmaceuticals Limited)
FDA approved Macleods Pharmaceuticals Limited's original ANDA for LINEZOLID (linezolid), making a generic linezolid available in the U.S. fo…
-
FDA approval · 2024-09-27FDA Approved: CEPHALEXIN — Original Application (Ascend Laboratories, LLC)
FDA approved an original application for Cepalexin (cephalexin) from Ascend Laboratories, LLC, establishing a generic cephalexin product.
-
FDA approval · 2024-05-01FDA Approved: AMOXICILLIN AND CLAVULANATE POTASSIUM — Supplemental Application (Northstar RxLLC)
FDA approved a supplemental application for Amoxicillin and clavulanate potassium (amoxicillin-clavulanate) from Northstar RxLLC, authorizin…
-
FDA approval · 2024-04-09FDA Approved: CEFPROZIL — Original Application (Ascend Laboratories, LLC)
FDA approved the original application for cefprozil from Ascend Laboratories, LLC, confirming it as a generic cephalosporin antibiotic.
-
FDA approval · 2024-04-05FDA Approved: DAPTOMYCIN — Supplemental Application (BE Pharmaceuticals Inc.)
The FDA approves BE Pharmaceuticals Inc.'s supplemental application for daptomycin. This action updates the regulatory status for the drug u…
-
FDA approval · 2024-03-14FDA Approved: DOXYCYCLINE — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' original application for doxycycline, a generic antibiotic, expanding the availability of doxycycline pr…
-
FDA label_change · 2023-11-22FDA Approved: METRONIDAZOLE — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental application for metronidazole from Prasco Laboratories, indicating an updated labeling/approval for an additiona…
-
FDA approval · 2023-10-12FDA Approved: PIPERACILLIN AND TAZOBACTAM — Original Application (Eugia US LLC)
FDA approved the original abbreviated new drug application for piperacillin and tazobactam, a combination antibiotic manufactured by Eugia U…
-
FDA approval · 2023-08-16FDA Approved: CLARITHROMYCIN — Supplemental Application (Lannett Company, Inc.)
FDA approved a supplemental application for a generic version of clarithromycin produced by Lannett Company, Inc.
-
FDA approval · 2022-12-06FDA Approved: NAFCILLIN — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a/ Avet Pharmaceuticals Inc.)
FDA approved a supplemental application for NAFCILLIN SODIUM (NAFCILLIN) from Heritage Pharmaceuticals Inc. (Avet Pharmaceuticals Inc.).
-
FDA approval · 2022-11-13FDA Approved: DAPTOMYCIN — Supplemental Application (BE Pharmaceuticals Inc.)
FDA approved a supplemental application for DAPTOMYCIN filed by BE Pharmaceuticals Inc. The approval relates to an ANDA and updates the regu…
-
FDA approval · 2022-11-02FDA Approved: AMOXICILLIN — Supplemental Application (USAntibiotics, LLC)
FDA approved a supplemental application for Amoxicillin submitted by USAntibiotics, LLC.
-
FDA approval · 2022-02-23FDA Approved: LINEZOLID — Supplemental Application (Ascend Laboratories, LLC)
FDA approved a supplemental application for LINEZOLID by Ascend Laboratories, LLC. The action approves changes to the product's labeling for…
-
FDA approval · 2021-11-12FDA Approved: VANCOMYCIN HYDROCHLORIDE — Supplemental Application (Plano Pharmaceuticals Inc.)
The FDA approved a supplemental application for Vancomycin hydrochloride by Plano Pharmaceuticals Inc., approving changes to the approved dr…
-
FDA approval · 2021-08-18FDA Approved: METRONIDAZOLE — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved a supplemental application for Metronidazole from Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
-
CLINICAL_TRIALS trial_result · 2021-07-28Clinical Trial Update: The Effect of Irrisept for Irrigation of Skin and Soft Tissue Infections (Irrisept USF Study) [NA]
Clinical trial update for Irrisept irrigation in skin and soft tissue infections shows terminated status with posted results.
-
CLINICAL_TRIALS trial_result · 2021-04-30Clinical Trial Update: Contezolid Acefosamil Versus Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infection [Phase 2]
Phase 2 trial comparing contezolid acefosamil to linezolid for acute bacterial skin and skin structure infections has completed with results…